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Abstract
It is widely accepted that the cell of origin of breast cancer is the adult mammary epithelial stem cell; however,
demonstrating the presence and location of tissue stem cells in the human breast has proved difficult. Furthermore,
we do not know the clonal architecture of the normal and premalignant mammary epithelium or its cellular
hierarchy. Here, we use deficiency in the mitochondrial enzyme cytochrome c oxidase (CCO), typically caused by
somatic mutations in the mitochondrial genome, as a means to perform lineage tracing in the human mammary
epithelium. PCR sequencing of laser-capture microdissected cells in combination with immunohistochemistry for
markers of lineage differentiation was performed to determine the clonal nature of the mammary epithelium.
We have shown that in the normal human breast, clonal expansions (defined here by areas of CCO deficiency)
are typically uncommon and of limited size, but can occur at any site within the adult mammary epithelium. The
presence of a stem cell population was shown by demonstrating multi-lineage differentiation within CCO-deficient
areas. Interestingly, we observed infrequent CCO deficiency that was restricted to luminal cells, suggesting that
niche succession, and by inference stem cell location, is located within the luminal layer. CCO-deficient areas
appeared large within areas of ductal carcinoma in situ, suggesting that the rate of clonal expansion was altered
in the premalignant lesion.
© 2017 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain
and Ireland.
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Introduction
The stem cell hierarchy of the human mammary epithe-
lium has been the subject of much debate. Previous stud-
ies suggest that stem cells in the normal human breast are
located within the luminal epithelial layer and also give
rise to the myoepithelial cells [1,2]. However, in vitro
studies show the possible existence of progenitor cells
that may differentiate into luminal cells from either the
myoepithelial or the luminal lineages, or indeed from
both [1–7]. There is further evidence for a subset of
luminal cells that express cytokeratin 5 (CK5) and can
give rise to both luminal and myoepithelial lineages.
This subset may also represent a stem cell population
and potentially act as cells of origin for breast cancer
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[8–10]. In addition, a recent study in human tissue com-
bining a novel 3D fractal model approach with a theoret-
ical model and with the expression of the putative stem
cell marker high aldehyde dehydrogenase (ALDH1A1)
has suggested that during morphogenesis of the mam-
mary gland, the intralobular branching ducts are the site
of cellular expansion and growth. This would indicate
that this site may be the location of stem cells within
the adult breast [11]. However, a novel analysis of mul-
ticolour lineage tracing at saturation during pubertal
development of the mouse mammary gland rules out the
presence and role of multipotent stem cells during adult
tissue remodelling [12].
Consequently, the location and characterization of
stem cells in the human breast are still unknown. The
major hindrance to our understanding of the location of
the human breast stem cell has been a lack of markers
that definitively demonstrate multi-lineage differentia-
tion and clonal expansion within tissue sections. To date,
no human lineage tracing studies have been performed
to show this. To determine the location of stem cells
within the human mammary epithelium, we have used
a lineage tracing technique where mitochondrial DNA
(mtDNA) mutations act as a marker of clonal expan-
sion [13]. Mutant cells are identified by the deficiency
of the mitochondrial enzyme cytochrome c oxidase
(CCO). Serial sections subjected to immunohistochem-
istry for lineage-specific markers, in combination with
sequencing of the mitochondrial genome from distinct
microdissected mammary epithelial cells, demonstrated
multi-lineage differentiation, which is the gold stan-
dard for stem cell identification [14]. MtDNA muta-
tions accumulate within normal tissue stem cells and
increase in frequency with age, reaching homoplasmy
or detectable levels of heteroplasmy in mid to late life
[15]. We have shown previously that this method allows
identification of the stem cell niche in the human stom-
ach [16], small bowel [17], and normal and premalignant
prostate [18]. Furthermore, somatic mtDNA mutations
are neutral, conferring no selective advantage or disad-
vantage permitting analysis of steady-state clonal com-
petition within the normal human mammary gland [19].
Here, we investigate in detail the clonal architecture
of the normal and premalignant epithelium in situ in the
human mammary gland. Stem cells have been long con-
sidered the likely origin of cancer [20,21]; therefore, our
findings may shine light not only on homeostasis of the
normal mammary gland but also on their contribution
to the origin of premalignant lesions and invasive can-
cer. Here, we show that clonal expansions demonstrating
multi-lineage differentiation from a single stem cell can
occur in any area of the normal human breast epithelium.
Ductal carcinoma in situ (DCIS) is considered unani-
mously to be a precursor of invasive ductal cancer (IDC),
because several studies have found a link between
genetic alterations which occur in the premalignant
lesion and are maintained in the invasive lesion [22–25].
However, the human DCIS stem cell has not been
identified, nor has the extent to which a stem cell’s
progeny can expand through the breast. Here, we show
lineage tracing within human DCIS that may provide an
insight into its cell of origin, a mode of expansion within
the human breast, and a potential understanding of the
neoplastic process.
Materials and methods
Tissue
Fresh-frozen and formalin-fixed, paraffin-embedded
(FFPE) clinical samples from patients undergoing
breast surgery between 2004 and 2009 at Barts Health
NHS Trust, London, UK were studied following patient
consent and approval from the local research ethics
committee and deposited in the Breast Cancer Now
tissue bank (formerly Breast Cancer Campaign tissue
bank; ref: [10]/H0308/49). Fresh-frozen DCIS clinical
samples were also obtained from the Erasmus Medical
Center Rotterdam, The Netherlands (MEC 02.953),
with the study adhering to the Code of Conduct of
the Federation of Medical Scientific Societies in The
Netherlands; from the Imperial College London Tissue
Bank, UK, following patient consent and approval from
the local research ethics committee (ref: ICHTB HTA;
licence: 12275; REC Wales approval: 12/WA/0196);
and from the Fondazione IRCSS, Istituto Nazionale
Tumori, Milano, Italy (ref: INT 199/15).
Enzyme histochemistry
Frozen sections (16 μm) of breast tissue underwent
sequential CCO and succinate dehydrogenase (SDH)
enzyme histochemistry, as described previously
[15]. CCO/SDH histochemistry permits the detec-
tion of CCO-normal cells (brown) contrasting with
CCO-deficient cells (blue due to SDH activity). In
brief, sections were incubated first in cytochrome c
medium [100mM cytochrome c, 4mM diaminobenzi-
dine tetrahydrochloride (brown chromogen), 20 μg/ml
catalase in 0.2 M phosphate buffer, pH 7.0; all from
Sigma Aldrich, Poole, UK] for 40min at 37 ∘C to allow
detection of CCO activity in brown, followed by washes
in PBS, pH 7.4, for 3 × 5min and then by incubation
in SDH medium (130mM sodium succinate, 200mM
phenazine methosulphate, 1mM sodium azide, 1.5mM
nitroblue tetrazolium in 0.2 M phosphate buffer, pH 7.0)
for 45min at 37 ∘C to allow detection of SDH activity
with nitroblue tetrazolium (blue chromogen). Sections
were allowed to dry in air for microdissection or dehy-
drated in increasing ethanol concentrations followed by
clearing in Histoclear (Fisher Scientific, Leicestershire,
UK). All images were captured using a Pannoramic 250
Flash III scanner and viewed using Pannoramic viewer
software (3D Histotech, Budapest, Hungary).
Immunohistochemistry
Five-micrometre-thick FFPE tissue sections were
dewaxed and subjected to boiling in 10mM sodium
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citrate buffer solution, pH 6.0 (Sigma, UK) for 20min.
Endogenous peroxidase activity was blocked with
3% hydrogen peroxide solution for 10min, followed
by a serum-free protein block (Dako, Ely, UK) for
10min. Sections were incubated for 1 h at room tem-
perature with primary antibody mouse anti-human
CCO (OxPhos Complex IV subunit I, 106E1A8; Life
Technologies, Paisley, UK) at a 1:100 dilution in
blocking serum, followed by incubation for 40min at
room temperature in biotin-conjugated goat anti-mouse
IgG (1:500; Dako). Sections were then incubated in
streptavidin-conjugated HRP (1:500; Dako) for 30min
at room temperature. Colour was developed with a DAB
Peroxidase (HRP) Substrate Kit (Vector Laboratories,
Peterborough, UK) according to the manufacturer’s rec-
ommendations and counterstained with haematoxylin,
before dehydration through alcohol, clearing in xylene,
and mounting.
Fluorescence immunohistochemistry
FFPE tissue sections were dewaxed and unmasked as
above. Fresh-frozen sections were fixed in an ice-cold
1:1 acetone–methanol solution for 5min at room tem-
perature. Sections were blocked with serum-free protein
block (Dako) for 40min. Sections were then incubated
for 1 h at room temperature with the primary antibodies
αSMA (1A4; Dako), CK18 (EPR1626; Abcam, Cam-
bridge, UK), both at a 1:50 dilution in blocking serum,
and mouse anti-CCO (OxPhos Complex IV subunit I;
1D6-E1A8; Life Technologies) at a 1:100 dilution in
blocking serum, followed by incubation for 40min at
room temperature in Alexa Fluor 488-conjugated goat
anti-mouse IgG or Alexa Fluor 594-conjugated goat
anti-rabbit IgG (Life Technologies) added at a 1:1500
dilution in blocking serum. Sections were mounted in
Prolong Gold anti-fade with DAPI (Invitrogen, Carls-
bad, CA, USA) and analysed using an Axioplan micro-
scope equipped with AxioCam MRc and AxioVision
software (Zeiss, Munich, Germany). In each analysis,
positive and negative controls were available. When
enzyme histochemistry was combined with IHC on
the same section, CCO histochemistry was performed
as described first, followed by fixation with a 1:1
acetone–methanol solution as above.
Extraction of mtDNA from microdissected tissue
Frozen sections (16 μm thick) were cut onto PALM
membrane slides (Zeiss) and air-dried at room tempera-
ture for 1 h and then subjected to enzymatic CCO stain-
ing as described above. Single cells or larger areas of
interest from mammary ducts and terminal duct lobu-
lar units (TDLUs) were then microdissected on a PALM
laser capture system (Zeiss) at a uniform laser power and
cutting width into PALM-specific 0.5ml tubes. Stromal
tissue was used as a control from each section. DNA
was extracted using QIAamp DNA Micro kits (Qiagen,
Hilden, Germany) according to the manufacturer’s pro-
tocol.
Sanger sequencing
A nested PCR protocol producing 36 500-bp over-
lapping fragments covering the entire mitochondrial
genome (mtDNA) was followed as described previously
[15]. PCR products were treated with ExoSaP-IT (GE
Healthcare, Little Chalfont, UK) according to the man-
ufacturer’s protocol and subjected to a Sanger sequenc-
ing reaction using Big Dye 3.1 (Life Technologies)
and then purified by ethanol precipitation and run on
an ABI Prism 3100 genetic analyzer (Life Technolo-
gies). Sequence traces were analysed using 4Peaks
software (http://nucleobytes.com/; formerly mekentosj
.com) together with Clustal W2 software (EMBL-EBI)
and compared with the revised Cambridge reference
sequence [26] and sequences from stromal controls and
CCO-normal specimens to eliminate polymorphisms
from the CCO-deficient sequences.
Results
Visualization of clonal expansions within normal
and pre-invasive (DCIS) human mammary
epithelium
To determine the presence of putative progenitor/stem
cells in the human breast, we first performed dual
enzyme histochemistry for CCO activity (brown) and
succinate dehydrogenase (blue, to highlight CCO defi-
ciency), which has been shown previously to high-
light clonally related cells [27]. We detected areas of
CCO deficiency in 9/45 patients’ (20%) normal breast
specimens and in 5/54 (9.2%) DCIS patients. CCO defi-
ciency in the normal breast was limited to small epithe-
lial patches. These CCO-deficient patches were detected
in terminal duct lobular units (TDLUs) (Figure 1A–D)
as well as in ducts (Figure 1E–H). CCO-deficient areas
were also detected in areas of DCIS, but were not
detected as frequently as in the normal breast. However,
CCO-deficient areas in DCIS appeared to be larger in
size, covering either part of or the entire cross-section of
the lesion (Figure 1I, J).
To formally demonstrate that patches of
CCO-deficient cells represent bona fide clonal expan-
sions, multiple CCO-deficient (blue) cells from both
normal and DCIS cases were non-contact laser-capture
microdissected and their entire mtDNA genome was
sequenced to reveal common mutations that would indi-
cate a common cell of origin. Figure 2 shows a TLDU
that possessed both CCO-deficient and CCO-normal
cells (Figure 2A–E). All microdissected cells from
CCO-deficient areas contained the same mtDNA
mutation (3127G>A), which was not present in the
surrounding CCO-proficient cells, demonstrating a
clonal expansion (Figure 2F). Clonal expansions were
also observed in CCO-deficient areas in ducts. Figure 3
shows a classical duct (Figure 2G, H) that contained
a small CCO-deficient area (Figure 2I–K) and each
deficient cell harboured a 1609 T>C mtDNA mutation
© 2017 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2017
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Figure 1. CCO-deficient patches of cells are found through the normal and premalignant human breast. (A) H&E staining showing a TDLU
in the normal adult breast. (B) CCO enzyme histochemistry identifies a subset of cells within the TDLU containing blue, CCO-deficient cells.
High-power images are shown in C and D, respectively. CCO deficiency is indicated by arrows. CCO-deficient ducts are also found in the
ducts of normal human breast. (E) H&E staining showing a normal duct from adult human breast. (F) CCO enzyme histochemistry identifies
three similarly distinct clusters of cells within the normal duct containing blue, CCO-deficient cells. High-power images are shown in G and
H, respectively. Scale bar= 150 μm; inset scale bar= 75 μm. (I) (and outlined area in J) CCO enzyme histochemistry of a sample of invasive
breast cancer with adjacent areas of DCIS identifies a large area of CCO-deficient blue cells within the premalignant lesion. CCO-deficient
cells are interspersed with wild-type CCO-positive brown cells, indicating dynamic mixing of clones in DCIS. Scale bar (I)= 2000 μm; inset
scale bar (J)= 250 μm. I’ and J’ represent globally saturated images (saturation set to 60) to highlight the CCO-deficient areas in I and J,
respectively.
(Figure 2L). These data suggest that clonal expansions
may arise within the normal human breast in both ductal
and TDLU epithelium.
In DCIS, CCO-deficient areas appeared much larger
than in normal breast epithelium: entire DCIS ducts
were clonal, each area containing a clonal mtDNA
mutation. Figure 3A shows an H&E-stained section of
an area of DCIS and Figure 3B shows the same area
stained for CCO activity. CCO-deficient DCIS ducts
(Figure 3Bi, ii) and a CCO-proficient duct (Figure
3Biii) were present. Distinct areas microdissected
from CCO-deficient ducts (Figure 3Ci, areas 1 and
2) shared a common 11867_11873insC mutation
(identified and shown as an insG mutation in the
reverse strand sequence, repeated on three indepen-
dent microdissected areas) that was not present in the
distant CCO-proficient cells (Figure 3Ciii, area 5).
The neighbouring CCO-deficient duct (Figure 3B, Ci)
was not related to this; however, it was clonal for a
heteroplasmic 957G>A mutation (Figure 3Cii, areas 3
and 4), and this was also not present in the surrounding
CCO-normal DCIS (Figure 3Ciii, area 5). These data
suggest that the rate of clonal expansion is higher
in neoplastic breast epithelium than in normal breast
epithelium and that multiple competing clones are
capable of arising within the same DCIS lesion.
Clonal populations in normal and neoplastic breast
epithelium contain multipotent stem cells
To investigate whether the clonal CCO-deficient areas
contain multipotent stem cells, we performed fluores-
cence immunohistochemistry to determine the expres-
sion pattern of markers for luminal and myoepithe-
lial cells to seek evidence of multi-lineage differentia-
tion, the gold standard for stem cell identification [14].
Figure 4A–L shows CCO-deficient epithelial cells in
© 2017 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2017
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Figure 2. Clonal expansions occur in both TDLUs and ducts. (A) H&E staining showing a TDLU in a normal adult breast and (B) at higher-power
magnification. (C) CCO enzyme histochemistry identifies a discrete TDLU containing blue, CCO-deficient cells and (D) at higher magnification.
(E) Post-laser capture microdissection of single cells from multiple CCO-deficient blue areas (arrowed in green) together with adjacent
CCO-normal brown cells (arrowed in purple, and one cell at greater distance in the section, not shown). Those cells without arrows failed to
PCR amplify. (F) All CCO-deficient cells shared a common, clonal point mutation (3127G> A) that was not present in the control CCO-normal
cells. This demonstrated clonal expansion within a TDLU. CCO-deficient ducts also show clonal expansions. (G) H&E staining showing a
normal duct in proximity to DCIS and (H) in higher magnification. (I) CCO enzyme histochemistry identifies clusters of blue, CCO-deficient
cells seen at higher-power magnification (J) pre- and (K) post-laser microdissection. (L) MtDNA sequencing of single cells from multiple
blue cells (arrowed in K) versus brown wild-type cells from a distant area (not shown) demonstrated that two blue cells from the larger blue
cluster (arrowed in green in K) shared a common, heteroplasmic 1609 T> C mutation that was also present in the single cell laser-captured
from a similarly distinct area (arrowed in green at the top of the image) but was not present in adjacent brown cells or in the other cells
laser-captured from distinct blue areas (arrowed in purple). These findings showed that normal ducts are clonal and that multiple clones
compete for the monoclonal conversion of the entire duct. Scale bar= 150 μm; inset scale bar= 75 μm.
© 2017 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2017
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Figure 3. DCIS ducts show multiple, large clonal expansions. (A) H&E staining showing adult breast with DCIS ducts. (B, Ci–iii) CCO
histochemistry on the serial section showing both CCO-deficient (Ci, ii) and CCO-proficient (Ciii) DCIS ducts. Areas 1 and 2 from Ci
show a shared 11867_118673insG mutation (shown in the reverse sequence strand) that was not detected in area 5 (Ciii). The adjacent
CCO-deficient duct (Cii, areas 3 and 4) did not share the same mutation but was clonal for a heteroplasmic 957G>A mutation that was also
not detected in area 5 (Ciii). Representative Sanger sequencing traces are shown below Ci–iii. Scale bar= 600 μm; inset scale bar= 300 μm.
serial sections of normal adult breast co-localized with
αSMA-positive myoepithelial cells and CK18-positive
luminal epithelial cells. This pattern was observed both
in normal adult breast and in DCIS (Figure 4M–P’).
While small clusters of fluorescent cells were observed
close to the myoepithelial layer in all stained sections
(CK18, αSMA, and CCO), they appeared to be autofluo-
rescent blood cells based on morphological features and
geographical location (H&E in supplementary material,
Figure S1). While we cannot exclude the possibility that
these cells could be myoepithelial cells, the vast major-
ity of, if not all, myoepithelial cells were CCO-negative.
This indicates that both the normal and the premalignant
mammary epithelium contain multipotent lineages, each
maintained by a dedicated population of stem cells.
Clones restricted to the luminal layer of normal
mammary ducts
Several studies have argued that mammary stem cells are
located in either, or both of, the luminal or myoepithelial
layers. A thorough investigation of all CCO-deficient
areas within our cohort of patients revealed a small
subset of normal breast samples (2/45; 4.5%) where
CCO-deficient patches were restricted to the luminal cell
layer (Figure 5), without involvement of the underlying
CCO-positive myoepithelial layers. We never detected
a sample in which CCO deficiency was restricted to
the myoepithelial layer, therefore suggesting that each
clone is derived from a dedicated progenitor cell located
within the luminal epithelial layer.
© 2017 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2017
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Figure 4. Multipotent stem cells reside within clonal CCO-negative normal and DCIS ducts. Immunofluorescence staining of serial sections
from a normal adult breast (A–H) showed that CCO-negative areas (lacking green CCO expression, F, G) contained cells positive for markers
of luminal cells (CK18, red) and myoepithelial cells (αSMA, green) (H), indicating that multipotent stem cells were present within the
CCO-deficient area and gave rise to the two differentiated cell types. Similarly, immunofluorescence staining of serial sections from a DCIS
sample (I–L; M–P and at higher-power magnification, M‘–P’) showed that CCO-negative areas (N, O and zoomed areas in N’, O’) contained
cells positive for CK18 and αSMA (green) (P and high power P’), which indicated the presence of multipotent stem cells within the DCIS
duct. Scale bar= 75 μm. Haematoxylin and Eosin show tissue structure (A,E,I,M,M’).
Discussion
Lineage tracing in murine models and in vitro stud-
ies have offered significant insight into the dynamics
of stem cells in the mammary gland [1,28], but the
translation of these findings to the normal human breast
is uncertain. In this study, using a combination of his-
tological and mitochondrial genetic analysis in human
tissues, we obtained evidence that the human adult
mammary epithelium is maintained by a population of
multipotent stem cells. Areas containing CCO-deficient
cells, which were clonal for mtDNA mutations, were
found in the normal adult human mammary epithe-
lium and were shown to contain cells of both luminal
andmyoepithelial lineages, thus demonstrating that both
mammary lineages derive from a long-lived and multi-
potent progenitor cell. It has been shown previously that
the accrual of a sufficient burden of somatic mutations
which result in CCO deficiency may take a consider-
able period of time (almost 40 years in the human colon)
[29]. We propose that CCO deficiency originates in the
stem cell population, since these are the only long-lived
cells within the epithelium. Consequently, the presence
of clonal CCO-deficient areas in the mammary epithe-
lium that spans both luminal and myoepithelial lineages
© 2017 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2017
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Figure 5. Normal breast contains CCO-deficient patches of cells restricted to the ductal luminal layer. (A, C) H&E staining showing two
ducts in the normal adult breast; high-power images are shown in A’ and C’, respectively. (B, D) CCO enzyme histochemistry identified
a subset of cells within the luminal layer of the ducts containing blue (CCO-deficient) cells. High-power images are shown in B’ and D’,
respectively. Scale bars: A, B= 150 μm; C, D= 300 μm; inset scale bars: A’, B’, C’, D’= 75 μm.
strongly indicates that a pool of multipotent stem cells
maintains the adult human mammary gland.
Areas containing CCO-deficient cells clonal for
mtDNA mutations were also found within TDLUs and
along lactiferous ducts, suggesting that a dedicated
stem cell population may not be restricted to a specific
compartment of the ductal–lobular system. Previous
studies, using a variety of putative markers and theoret-
ical models, have proposed that mammary gland stem
cells are found at the branch points of side-ducts [30],
in the ducts [10], or in TDLUs, in particular at the edge
of growing ductules [11,31]. A more recent study in
the mouse mammary gland excluded the presence of
multipotent progenitor cells, but localized unipotent pro-
genitors sporadically in branching ducts or alveoli [32].
Our data do not suggest such a restriction between
the regions of the ductal–lobular system, but indicate
that multipotent, dividing stem cells are localized along
© 2017 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2017
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the whole adult mammary epithelium. Furthermore, the
presence of multiple CCO-deficient areas of various
sizes within the same duct provides an insight into clonal
dynamics and clonal competition in the normal epithe-
lium. Smaller CCO-deficient areas may represent a new
clonal expansion or a clone headed towards extinction,
whereas larger CCO-deficient areas may represent a
dominant clone that could eventually lead to a mon-
oclonal conversion of the duct, similarly to the pro-
cess of crypt purification in the human normal colon
[33]. We observed mainly areas of CCO deficiency that
extended through both layers of the mammary duct:
however, in two samples we could detect the presence
of CCO-deficient cells restricted to the luminal layer.
This could indicate a differentiation hierarchy relat-
ing the two ductal lineages, where the progenitor cells
are located in the luminal layer, expand horizontally
within this, and only successively derive the myoepithe-
lial layer. We could not detect any case where CCO defi-
ciency was associated uniquely with the myoepithelial
layer, supporting previous findings that concluded that
the luminal layer is the location of mammary epithelial
progenitor cells [2].
CCO-deficient clonal areas were also detected in duc-
tal carcinoma in situ (DCIS), encompassing partial or
entire cross-sections. Although we have no data to show
directly the cell of origin of DCIS, we can propose that
DCIS originates from stem cells in the luminal layer, as
it is likely that this is the cell of origin of clonal expan-
sions within the breast.We observed larger areas of CCO
deficiency in DCIS compared with normal breast: if we
assume that CCO-deficient cells represent a snapshot in
time of the dynamics of the stem cell populations within
the tissue, our findings would indicate an increase in
stem cell number in the premalignant lesion.
In summary, we have shown that the adult human
breast contains a population of stem cells localized in
the whole ductal–lobular system which maintain the
normal epithelium by differentiating into both luminal
and myoepithelial cells. This architecture is preserved
in DCIS but clonal dynamics are altered, and an increase
in the size of expanded clones was observed within the
premalignant lesions compared with the normal breast.
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